Cognitive and affective benefits of combination therapy with galantamine plus cognitive rehabilitation for Alzheimer's disease

Geriatrics and Gerontology International

Volumn 16, Issue 4, 2016, Pages 440-445

  Tokuchi, Ryo ^a,b   Hishikawa, Nozomi ^a   Matsuzono, Kosuke ^a   Takao, Yoshiki ^c   Wakutani, Yosuke ^c   Sato, Kota ^a   Kono, Syoichiro ^a   Ohta, Yasuyuki ^a   Deguchi, Kentaro ^a   Yamashita, Toru ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Okayama Institute for Medical and Technical Sciences   (Japan)

^c Kurashiki Heisei Hospital   (Japan)

Author keywords

Affective function; Alzheimer's disease; Cognitive function; Combination therapy; Galantamine

Indexed keywords

GALANTAMINE; CHOLINESTERASE INHIBITOR;

ABE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOM OF DEMENTIA SCORE; AFFECT; AGED; ALZHEIMER DISEASE; APATHY SCALE; ARTICLE; COGNITION; COGNITIVE REHABILITATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FRONTAL ASSESSMENT BATTERY; GERIATRIC DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SPEECH THERAPY; TREATMENT DURATION; TREATMENT RESPONSE; COGNITIVE THERAPY; DRUG EFFECTS; FOLLOW UP; PHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; TIME FACTOR; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COGNITION; COGNITIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; GALANTAMINE; HUMANS; MALE; PHYSICAL THERAPY MODALITIES; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929646276     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12488     Document Type: Article

References (30)

1. Di Iulio F, Palmer K, Blundo C etal. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes. Int Psychogeriatr 2010; 22: 629-640.
2. Launer LJ, Andersen K, Dewey ME etal. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999; 52: 78-84.
3. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 2000; 54: 2072-2077.
4. Li J, Wang YJ, Zhang M etal. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011; 76: 1485-1491.
5. Tokuchi R, Hishikawa N, Kurata T etal. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition. J Neurol Sci 2014; 346: 288-292.
6. Van de Winckel A, Feys H, De Weerdt W, Dom R. Cognitive and behavioural effects of music-based exercises in patients with dementia. Clin Rehabil 2004; 18: 253-260.
7. Onder G, Zanetti O, Giacobini E etal. Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial. Br J Psychiatry 2005; 187: 450-455.
8. Dooley NR, Hinojosa J. Improving quality of life for persons with Alzheimer's disease and their family caregivers: brief occupational therapy intervention. Am J Occup Ther 2004; 58: 561-569.
9. Olazarán J, Muñiz R, Reisberg B etal. Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease. Neurology 2004; 63: 2348-2353.
10. Requena C, Maestú F, Campo P, Fernández A, Ortiz T. Effects of cholinergic drugs and cognitive training on dementia: 2-year follow-up. Dement Geriatr Cogn Disord 2006; 22: 339-345.
11. Matsuzono K, Hishikawa N, Takao Y etal. Combination Benefit of Cognitive Rehabilitation plus Donepezil for Alzheimer's Disease Patients. Geriatr Gerontol Int 2015. doi: 10.1111/ggi.12455.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
13. Dubois D, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626.
14. Yesavage JA. Geriatric depression scale. Psychopharmacol Bull 1988; 24: 709-711.
15. Starkstein SE, Fedoroff JP, Price TR, Leiguarda R, Robinson RG. Apathy following cerebrovascular lesions. Stroke 1993; 24: 1625-1630.
16. Abe K, Yamashita T, Hishikawa N etal. A new simple score (ABS) for assessing behavioral and psychological symptoms of dementia. J Neurol Sci 2015; 350: 14-17. doi: 10.1016/j.jns.2015.01.029.
17. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006; 16: 916-928.
18. Cormack F, Aarsland D, Ballard C, Tovée MJ. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry 2004; 19: 371-377.
19. Ogawa K, Inui T. The role of the posterior parietal cortex in drawing by copying. Neuropsychologia 2009; 47: 1013-1022.
20. Melrose RJ, Harwood D, Khoo T, Mandelkern M, Sultzer DL. Association between cerebral metabolism and Rey-Osterrieth Complex Figure Test performance in Alzheimer's disease. J Clin Exp Neuropsychol 2013; 35: 246-258.
21. Pardo JV, Pardo PJ, Janer KW, Raichle ME. The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci U S A 1990; 87: 256-259.
22. van Paasschen J, Clare L, Yuen KS etal. Cognitive rehabilitation changes memory-related brain activity in people with Alzheimer disease. Neurorehabil Neural Repair 2013; 27: 448-459.
23. Aguirre E, Woods RT, Spector A, Orrell M. Cognitive stimulation for dementia: a systematic review of the evidence of effectiveness from randomised controlled trials. Ageing Res Rev 2013; 12: 253-262.
24. Toba K, Nakamura Y, Endo H etal. Intensive rehabilitation for dementia improved cognitive function and reduced behavioral disturbance in geriatric health service facilities in Japan. Geriatr Gerontol Int 2014; 14: 206-211.
25. Davis RN, Massman PJ, Doody RS. Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study. Alzheimer Dis Assoc Disord 2001; 15: 1-9.
26. Cahn-Weiner DA, Malloy PF, Rebok GW, Ott BR. Results of a randomized placebo-controlled study of memory training for mildly impaired Alzheimer's disease patients. Appl Neuropsychol 2003; 10: 215-223.
27. Viola LF, Nunes PV, Yassuda MS etal. Effects of a multidisciplinary cognitive rehabilitation program for patients with mild Alzheimer's disease. Clinics 2011; 66: 1395-1400.
28. Bassuk SS, Glass TA, Berkman LF. Social disengagement and incident cognitive decline in community-dwelling elderly persons. Ann Intern Med 1999; 131: 165-173.
29. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B. Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 2000; 355: 1315-1319.
30. Wang HX, Karp A, Winblad B, Fratiglioni L. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol 2002; 155: 1081-1087.